Skip to content
20-F/A

Annual Report (Foreign)

CHINA NUOKANG BIO-PHARMACEUTICAL INC.

0001193125-12-232619

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2011 · Dec 31, 2011 155.87M sh
Shares Diluted FY 2011 · Dec 31, 2010 158.8M sh
Shares Diluted FY 2011 · Dec 31, 2009 99.73M sh
Shares Outstanding FY 2011 · Dec 31, 2011 158.29M sh
Stock Repurchased FY 2011 · Dec 31, 2011 $2.7M
Stock Repurchased FY 2011 · Dec 31, 2011 ¥16.96M
Capex FY 2011 · Dec 31, 2011 $9.07M
Capex FY 2011 · Dec 31, 2011 ¥57.08M
Capex FY 2011 · Dec 31, 2010 ¥32.75M
Capex FY 2011 · Dec 31, 2009 ¥26.85M
Operating Cash Flow FY 2011 · Dec 31, 2011 $13.04M
Operating Cash Flow FY 2011 · Dec 31, 2011 ¥82.05M
Operating Cash Flow FY 2011 · Dec 31, 2010 −¥21.17M
Operating Cash Flow FY 2011 · Dec 31, 2009 ¥9.11M
Long Term Debt FY 2011 · Dec 31, 2011 $2.06M
Long Term Debt FY 2011 · Dec 31, 2011 ¥12.93M
Long Term Debt FY 2011 · Dec 31, 2010 ¥11.3M
Short Term Debt FY 2011 · Dec 31, 2011 $1.11M
Short Term Debt FY 2011 · Dec 31, 2011 ¥7M
Short Term Debt FY 2011 · Dec 31, 2010 ¥47M
Cash And Equivalents FY 2011 · Dec 31, 2011 $28.5M
Cash And Equivalents FY 2011 · Dec 31, 2011 ¥179.39M
Cash And Equivalents FY 2011 · Dec 31, 2010 $30.48M
Cash And Equivalents FY 2011 · Dec 31, 2010 ¥191.82M
Cash And Equivalents FY 2011 · Dec 31, 2009 ¥351.26M
Cash And Equivalents FY 2011 · Dec 31, 2008 ¥81.84M
Stockholders Equity FY 2011 · Dec 31, 2011 $97.38M
Stockholders Equity FY 2011 · Dec 31, 2011 ¥612.87M
Stockholders Equity FY 2011 · Dec 31, 2010 ¥635.71M
Current Liabilities FY 2011 · Dec 31, 2011 $7.84M
Current Liabilities FY 2011 · Dec 31, 2011 ¥49.33M
Current Liabilities FY 2011 · Dec 31, 2010 ¥72.11M
Total Liabilities FY 2011 · Dec 31, 2011 $13.9M
Total Liabilities FY 2011 · Dec 31, 2011 ¥87.49M
Total Liabilities FY 2011 · Dec 31, 2010 ¥107.08M
Current Assets FY 2011 · Dec 31, 2011 $64.37M
Current Assets FY 2011 · Dec 31, 2011 ¥405.11M
Current Assets FY 2011 · Dec 31, 2010 ¥484.32M
Total Assets FY 2011 · Dec 31, 2011 $111.59M
Total Assets FY 2011 · Dec 31, 2011 ¥702.31M
Total Assets FY 2011 · Dec 31, 2010 ¥744.88M
Eps Diluted FY 2011 · Dec 31, 2011 −$0.01
Eps Diluted FY 2011 · Dec 31, 2011 −¥0.09
Eps Diluted FY 2011 · Dec 31, 2010 ¥0.30
Eps Diluted FY 2011 · Dec 31, 2009 ¥0.51
Eps Basic FY 2011 · Dec 31, 2011 −$0.01
Eps Basic FY 2011 · Dec 31, 2011 −¥0.09
Eps Basic FY 2011 · Dec 31, 2010 ¥0.30
Eps Basic FY 2011 · Dec 31, 2009 ¥0.52
Sga Expense FY 2011 · Dec 31, 2011 $11.31M
Sga Expense FY 2011 · Dec 31, 2011 ¥71.19M
Sga Expense FY 2011 · Dec 31, 2010 ¥53.53M
Sga Expense FY 2011 · Dec 31, 2009 ¥47.58M
Rd Expense FY 2011 · Dec 31, 2011 $2.5M
Rd Expense FY 2011 · Dec 31, 2011 ¥15.74M
Rd Expense FY 2011 · Dec 31, 2010 ¥13.5M
Rd Expense FY 2011 · Dec 31, 2009 ¥8.3M
Net Income FY 2011 · Dec 31, 2011 −$2.23M
Net Income FY 2011 · Dec 31, 2011 −¥14.01M
Net Income FY 2011 · Dec 31, 2010 ¥46.06M
Net Income FY 2011 · Dec 31, 2009 ¥65.1M
Operating Income FY 2011 · Dec 31, 2011 $2.96M
Operating Income FY 2011 · Dec 31, 2011 ¥18.66M
Operating Income FY 2011 · Dec 31, 2010 ¥65.91M
Operating Income FY 2011 · Dec 31, 2009 ¥80.89M
Gross Profit FY 2011 · Dec 31, 2011 $39.69M
Gross Profit FY 2011 · Dec 31, 2011 ¥249.81M
Gross Profit FY 2011 · Dec 31, 2010 ¥278.49M
Gross Profit FY 2011 · Dec 31, 2009 ¥247.29M
Cost Of Revenue FY 2011 · Dec 31, 2011 $6.11M
Cost Of Revenue FY 2011 · Dec 31, 2011 ¥38.46M
Cost Of Revenue FY 2011 · Dec 31, 2010 ¥37.3M
Cost Of Revenue FY 2011 · Dec 31, 2009 ¥35.63M
Revenue FY 2011 · Dec 31, 2011 $45.8M
Revenue FY 2011 · Dec 31, 2011 ¥288.27M
Revenue FY 2011 · Dec 31, 2010 ¥315.79M
Revenue FY 2011 · Dec 31, 2009 ¥282.91M
Short Term Investments FY 2011 · Dec 31, 2010 ¥29.87M